Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Genital Neoplasms, Male × (225)Ac-PSMA-617 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Urogenital Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Neoplasms by Site 1 Neoplasms 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1 Disease 1

Interventions

niraparib 1 gallium 68 PSMA-11 1 apalutamide 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04597411 2025-03-21

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

Endocyte

Phase 1 Recruiting

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡